HGS founders join IMS Health team
October 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HGS, IMS Health, mcfarlane
Healthcare services firm IMS Health has appointed HGS Europe founders Graeme McFarlane and Angela McFarlane (pictured) to its UK team.
NICE ‘yes’ for Jetrea
October 23, 2013Sales and Marketing Jetrea, NHS, NICE, eye
Jetrea has completed its seemingly inexorable journey to NHS use in England and Wales for a rare eye condition following …
AZ begins late-stage trial of new cancer drug
October 22, 2013Research and Development, Sales and Marketing AstraZeneca, Cancer, NSCLC, selumetinib
AstraZeneca has begun a Phase III study for its investigational lung cancer pill selumetinib in patients with a genetic sub-type …
US regulator ponders Arzerra
October 22, 2013Sales and Marketing Arzerra, CLL, FDA, GSK
GlaxoSmithKline and Genmab have submitted their blood cancer drug Arzerra to the FDA as a first-line treatment for chronic lymphocytic …
Former GSK director joins Publicis Life Brands Resolute
October 22, 2013Manufacturing and Production, Research and Development, Sales and Marketing GSK, PLBR, publicis
Former director of branding and communications at GlaxoSmithKline Consumer Health Sian Dodwell, has joined Publicis Life Brands Resolute (PLBR) from …
Opsumit wins US approval
October 22, 2013Sales and Marketing actelion fda, opsumit
The FDA has approved Actelion’s oral endothelin receptor antagonist Opsumit as a treatment for pulmonary arterial hypertension (PAH), a potentially …
Effectively outsourcing medical and laboratory equipment procurement
October 21, 2013With Investigator Sites located across the World it is increasingly important to ensure that they all have the right equipment …
Ariad ditches CML trial
October 21, 2013Research and Development, Sales and Marketing Ariad, CML, iclusig
Ariad Pharmaceuticals has ditched its late-stage trial of Iclusig in patients with newly-diagnosed chronic myeloid leukemia (CML) after blood clots …
Eisai: reform NICE or we’ll pull out of the UK
October 21, 2013Research and Development, Sales and Marketing Eisai, Hatfield, Hunt, NICE
Eisai has criticised NICE for being too narrow minded on assessing new drugs, and has warned it may pull its …
No closer to Alzheimer’s cure despite rise in research
October 21, 2013Research and Development, Sales and Marketing Alzheimer's, depression, markram
A scientist charged with developing a digital model of the human brain has said that patients with neurological and neurodegenerative …
The new paradigm in oncology drug marketing
October 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology
Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …
Mylan hires president of European business
October 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, glinka
Mylan has announced that from December Jacek Glinka will be the president of its European business. Glinka served as chief …
Dust settles on US shutdown
October 21, 2013Medical Communications, Sales and Marketing FDA, Obamacare, PhRMA, shutdown
The FDA has said that it was able to carry out a significant part of its remit during the suspension …
MHRA recalls five Wockhardt medicines
October 18, 2013Manufacturing and Production FDA, GMP, MHRA, Violations, Wockhardt, recall
The UK drugs regulator has recalled five more generic medicines made by Indian drugmaker Wockhardt after an inspection uncovered quality …
Shire slated following Adderall T-shirt controversy
October 18, 2013Medical Communications, Sales and Marketing Adderall, EMA, FDA, Shire
A senior doctor and patient welfare advocate has criticised Shire after T-shirts emblazoned with the word ‘Adderall’ appeared for sale …
Roche rules out merger talk
October 18, 2013Sales and Marketing Cancer, Herceptin, Novartis, Roche, merger
Roche has dismissed talk of merging with fellow Swiss manufacturer Novartis as it revealed its results for the last three …
SCM Pharma appoints new director
October 18, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing SCM Pharma, simon bellamy
Contract development and manufacturing organisation SCM Pharma has expanded its commercial management team with the appointment of a new director. …
Astellas gets NICE nod
October 18, 2013Sales and Marketing Cancer, NHS, NICE, Xtandi
Astellas Pharma’s new prostate cancer drug Xtandi which has been shown to shrink and kill cancer cells, has been recommended …
Travel ban ambiguity for GSK ‘s former China boss
October 17, 2013Sales and Marketing China, GSK, bribery, reilly
GlaxoSmithKline has refuted reports that its former chief of Chinese operations is barred from leaving the country while he assists …
Quest starts selling BRCA tests
October 17, 2013Sales and Marketing BRCA, Myriad, Quest, jolie
Quest Diagnostics has begun selling a genetic test to uncover the risk of hereditary breast cancer, after the US Supreme …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
